One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease

Fabry nephropathy is associated with progressive accumulation of globotriaosylceramide (GL3) in podocytes. Reducing this GL3 burden may reduce podocyte injury. Sensitive methods to quantify podocyte GL3 content may determine whether a given strategy can benefit podocytes in Fabry disease. We develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Najafian, Behzad, Tøndel, Camilla, Svarstad, Einar, Sokolovkiy, Alexey, Smith, Kelly, Mauer, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833322/
https://www.ncbi.nlm.nih.gov/pubmed/27081853
http://dx.doi.org/10.1371/journal.pone.0152812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833322/
https://www.ncbi.nlm.nih.gov/pubmed/27081853
http://dx.doi.org/10.1371/journal.pone.0152812

Ejemplares similares